[Segidrin: a new-type antineoplastic agent].
Filov
V A
VA
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005943:Gluconeogenesis; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D000970:Antineoplastic Agents; D006834:Hydrazines; C029424:hydrazine